Literature DB >> 35377455

DDRGK1 is required for the proper development and maintenance of the growth plate cartilage.

Monika Weisz-Hubshman1, Adetutu T Egunsula1, Brian Dawson1, Alexis Castellon1, Ming-Ming Jiang1, Yuqing Chen-Evenson1, Yu Zhiyin1, Brendan Lee1, Yangjin Bae1.   

Abstract

Loss-of-function mutations in DDRGK1 have been shown to cause Shohat type spondyloepimetaphyseal dysplasia (SEMD). In zebrafish, loss of function of ddrgk1 leads to defects in early cartilage development. Ddrgk1-/- mice show delayed mesenchymal condensation in the limb buds and early embryonic lethality. Mechanistically, Ddrgk1 interacts with Sox9 and reduces ubiquitin-mediated proteasomal degradation of Sox9 protein. To investigate the cartilage-specific role of DDRGK1, conditional knockout mice were generated by intercrossing Prx1-Cre transgenic mice with Ddrgkfl/fl mice to delete its expression in limb mesenchymal cells. Mutant mice showed progressive severe shortening of the limbs and joint abnormalities. The growth plate showed disorganization with shortened proliferative zone and enlarged hypertrophic zone. In correlation with these findings, Sox9 and Col2a1 protein levels were decreased, while Col10a1 expression was expanded. These data demonstrate the importance of Ddrgk1 during growth plate development. In contrast, deletion of Ddrgk1 with the osteoblast-specific Osteocalcin-Cre and Leptin receptor-Cre lines did not show bone phenotypes, suggesting that the effect on limb development is cartilage-specific. To evaluate the role of DDRGK1 in cartilage postnatal homeostasis, inducible Agc1-CreERT2; Ddrgklfl/fl mice were generated. Mice in which Ddrgk1 was deleted at 3 months of age showed disorganized growth plate, with significant reduction in proteoglycan deposition. These data demonstrate a postnatal requirement for Ddrgk1 in maintaining normal growth plate morphology. Together, these findings highlight the physiological role of Ddrgk1 in the development and maintenance of the growth plate cartilage. Furthermore, these genetic mouse models recapitulate the clinical phenotype of short stature and joint abnormalities observed in patients with Shohat type SEMD.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2022        PMID: 35377455      PMCID: PMC9402238          DOI: 10.1093/hmg/ddac078

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   5.121


  35 in total

1.  Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia.

Authors:  Adetutu T Egunsola; Yangjin Bae; Ming-Ming Jiang; David S Liu; Yuqing Chen-Evenson; Terry Bertin; Shan Chen; James T Lu; Lisette Nevarez; Nurit Magal; Annick Raas-Rothschild; Eric C Swindell; Daniel H Cohn; Richard A Gibbs; Philippe M Campeau; Mordechai Shohat; Brendan H Lee
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

2.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; James F Martin; Andreas Schedl; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

3.  Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer.

Authors:  W Huang; X Zhou; V Lefebvre; B de Crombrugghe
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Ontogeny of the expression of leptin and its receptor in the murine fetus and placenta.

Authors:  N Hoggard; L Hunter; R G Lea; P Trayhurn; J G Mercer
Journal:  Br J Nutr       Date:  2000-03       Impact factor: 3.718

Review 5.  Chondrodysplasias due to proteoglycan defects.

Authors:  Nancy B Schwartz; Miriam Domowicz
Journal:  Glycobiology       Date:  2002-04       Impact factor: 4.313

6.  Novel spondyloepimetaphyseal dysplasia due to UFSP2 gene mutation.

Authors:  M Di Rocco; M Rusmini; F Caroli; A Madeo; M Bertamino; G Marre-Brunenghi; I Ceccherini
Journal:  Clin Genet       Date:  2018-01-12       Impact factor: 4.438

7.  Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.

Authors:  Mei Zhang; Shouhong Xuan; Mary L Bouxsein; Dietrich von Stechow; Nagako Akeno; Marie Claude Faugere; Hartmut Malluche; Guisheng Zhao; Clifford J Rosen; Argiris Efstratiadis; Thomas L Clemens
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

8.  Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow.

Authors:  Bo O Zhou; Rui Yue; Malea M Murphy; James G Peyer; Sean J Morrison
Journal:  Cell Stem Cell       Date:  2014-06-19       Impact factor: 24.633

Review 9.  New gene discoveries in skeletal diseases with short stature.

Authors:  Alice Costantini; Mari H Muurinen; Outi Mäkitie
Journal:  Endocr Connect       Date:  2021-04-01       Impact factor: 3.335

10.  Generation of a Quantitative Luciferase Reporter for Sox9 SUMOylation.

Authors:  Hideka Saotome; Atsumi Ito; Atsushi Kubo; Masafumi Inui
Journal:  Int J Mol Sci       Date:  2020-02-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.